Glymidine sodium
Glymidine sodium is a sulfonylurea-class hypoglycemic agent that promotes the release of insulin from pancreatic beta cells. It is utilized in diabetes research for investigating insulin secretion mechanisms in both in vitro cellular assays and in vivo animal models of hyperglycemia.
Product Specifications
CAS Number
3459-20-9
Product Name Alternative
Antidiabetic, oral, inhibit, Glymidine, Glymidine sodium, Gondafon, Glycodiazine, glucose, endogenous lipid mobilization, hepatic lipolysis, Inhibitor, pyruvate oxidation
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
98.03% (May vary between batches)
Solubility
DMSO:60 mg/mL (181.09 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.04 mM)
Smiles
O=S ([N-]C1=NC=C (C=N1) OCCOC) (C2=CC=CC=C2) =O.[Na+]
Molecular Formula
C13H14N3NaO4S
Molecular Weight
331.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-319257 500 mg
(6-Bromo-1H-benzoimidazol-2-ylsulfanyl) -acetic acid
Sign In for Pricing
View Details